At i+Med, we celebrate a new milestone in our scientific journey. Our colleague Luis Andrés Pérez recently defended his doctoral thesis titled “Development of Hydrogel Formulations Based on Hyaluronic Acid: Contribution to Industrial Injectable Biomaterials”, earning the cum laude distinction unanimously.
This research, developed in collaboration with i+Med and the NanoPolyandGel Group (ICTP-CSIC), is part of an industrial project aimed to the development of injectable formulations in collaboration with the company i+Med and the NanoPolyandGel Group (ICTP-CSIC). Thiol group chemistry was selected to develop injectable formulations based on hyaluronic acid. In addition, further HA formulations were achieved by combining HA with polysaccharides, such as chitosan and pectin, to produce interpenetrating polymer networks with improved mechanical performance and modulated degradation properties. A mechanical fragmentation methodology was implemented with an industrial and scalable approach to produce stable, sterile and ready-to-use injectable formulations.
The defense took place in Madrid, at the ICTP-CSIC headquarters, under the supervision of:
- Rebeca Hernández Velasco, Principal Investigator at ICTP-CSIC.
- Virginia Sáez Martínez, Researcher at i+Med.
- Dr. José María Alonso Carnicero, Researcher at i+Med.
The thesis committee included:
- María Rosa Aguilar de Armas (President), Senior Scientist at ICTP-CSIC.
- Marcelo Calderón (Secretary), Ikerbasque Research Professor at POLYMAT.
- Anisa Mahomed (Member), Associate Professor at Aston University, United Kingdom.
Luis Andrés Pérez continues to demonstrate that talent, dedication, and teamwork are the pillars of scientific and technological progress. At i+Med, we deeply appreciate his contributions to our mission of advancing innovation in biomaterials.
Congratulations Luis!